Vijaya Diagnostic Centre Limited — Others, 12-05-2025: ESOP/ESOS/ESPS

Vijaya Diagnostic Centre has announced a board meeting on which it approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2025, with clean audit reports. A final dividend of ₹2 per share (200%) has been proposed, pending shareholder approval. Mr. S. Ramachandra Reddy joins as Interim CFO, and Mr. Lanka Sai Srinivas as Chief Technology Officer, both immediately effective. Santhosh & Associates continue as Cost Auditors for FY2025-26. The company granted 1,91,150 employee stock options at ₹815 each, vesting based on performance and tenure.